Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9B02N008
Published by: Ivey Publishing
Originally published in: 2002
Version: 2002-04-18
Length: 14 pages
Data source: Field research

Abstract

Hemosol is a small biotech company that is under pressure to meet its research and development targets. The company is anticipating the completion of the second phase of testing of one of its products within the next year. Before the company can move on to the next phase of testing, Hemosol must obtain more capital. The company will need to rely on the investment community for funding, however, they have been struggling with developing relationships with investors. Hemosol''s president has approached the executive vice-president of the Equicom Group Inc, an investor relations firms, for assistance in putting a strategic plan together to improve the company''s performance and reputation.
Location:
Size:
Small
Other setting(s):
1998

About

Abstract

Hemosol is a small biotech company that is under pressure to meet its research and development targets. The company is anticipating the completion of the second phase of testing of one of its products within the next year. Before the company can move on to the next phase of testing, Hemosol must obtain more capital. The company will need to rely on the investment community for funding, however, they have been struggling with developing relationships with investors. Hemosol''s president has approached the executive vice-president of the Equicom Group Inc, an investor relations firms, for assistance in putting a strategic plan together to improve the company''s performance and reputation.

Settings

Location:
Size:
Small
Other setting(s):
1998

Related